Mark G Currie's Net Worth

$15.2 Million

Estimate Recalculated Sep 18, 2024 08:06PM EST

Who is Mark G Currie

Mark G Currie has an estimated net worth of $15.2 Million. This is based on reported shares across multiple companies, which include IRONWOOD PHARMACEUTICALS INC, and Cyclerion Therapeutics, Inc..

SEC CIK

Mark G Currie's CIK is 0001478244

Past Insider Trading and Trends

2019 was Mark G Currie's most active year for acquiring shares with 26 total transactions. Mark G Currie's most active month to acquire stocks was the month of March. 2018 was Mark G Currie's most active year for disposing of shares, totalling 26 transactions. Mark G Currie's most active month to dispose stocks was the month of January. 2019 saw Mark G Currie paying a total of $4,000,284.67 for 2,857,886 shares, this is the most they've acquired in one year. In 2019 Mark G Currie cashed out on 1,302,245 shares for a total of $3,839,794.92, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

IRONWOOD PHARMACEUTICALS INC

Chief Scientific Officer
Updated Jun 21, 2024
Form 4
4.47%
24.31K
Jun 21, 2024
568.42K
Grant
Jun 18
Form 4
4.28%
22.35K
Jun 22, 2023
544.11K
Grant
Jun 20
Form 4
-11.83%
-70.00K
$11.78
-$824.60K
Aug 15, 2022
521.76K
Sale
Aug 11
Form 4
-24.34%
-190.38K
$11.83
-$68.54K
Jun 09, 2022
591.76K
Sale
ScheduledJun 07
Form 4
3.78%
21.57K
Jun 03, 2022
591.76K
Grant
Jun 01
Form 4
-3.97%
-23.57K
$11.59
-$273.19K
Jun 16, 2021
570.19K
Sale
ScheduledJun 14
Form 4
3.99%
22.77K
Jun 04, 2021
593.76K
Grant
Jun 02
Form 4
3.95%
21.72K
Jun 05, 2020
570.99K
Grant
Jun 03
Form 4
-9.13%
-60.00K
$10.86
-$208.20K
Jan 24, 2020
596.98K
Sale
ScheduledJan 23
Form 4
-1.59%
-8.89K
$11.41
-$24.71K
Jan 21, 2020
549.27K
Sale
ScheduledJan 16
Form 4
-0.42%
-2.34K
Dec 18, 2019
549.27K
Grant
Dec 16 - Dec 17
Form 4
4.29%
22.71K
May 31, 2019
551.61K
Grant
May 29
Form 4
-0.76%
-4.05K
$10.53
-$42.70K
May 14, 2019
528.90K
Sale
ScheduledMay 10
Form 4
-43.33%
-964.73K
Apr 03, 2019
1.43M
Disposition
Apr 01
Form 4
-34.23%
-275.00K
$13.26
-$3.65M
Mar 08, 2019
528.48K
Sale
Mar 07 - Mar 08
Form 4
-0.20%
-1.64K
$14.31
-$23.53K
Feb 22, 2019
803.48K
Sale
ScheduledFeb 20 - Feb 21
Form 4
600.00K
Jan 31, 2019
600.00K
Grant
Jan 29
Form 4
Jan 03, 2019
825.12K
Acq/Dis
Dec 31
Form 4
-50.16%
-233.30K
$14.33
-$1.62M
Oct 09, 2018
1.01M
Sale
ScheduledOct 04 - Oct 05
Form 4
-7.56%
-65.00K
$11.67
-$873.57K
Aug 28, 2018
825.12K
Sale
ScheduledAug 24
Form 4
-11.75%
-130.00K
$11.70
-$1.75M
Aug 24, 2018
1.01M
Sale
ScheduledAug 22 - Aug 23
Form 4
66.21%
12.00K
Aug 02, 2018
805.12K
Grant
Jul 31
Form 4
1,079.90%
213.37K
$14.66
-$23.95K
Feb 22, 2018
1.01M
Grant
ScheduledFeb 21
Form 4
-7.19%
-60.00K
$9.61
-$701.40K
Jan 26, 2018
794.76K
Sale
ScheduledJan 24
Form 4
-7.06%
-1.50K
Dec 11, 2017
794.76K
Grant
Dec 07
Form 4
-6.70%
-60.00K
$7.09
-$1.02M
Mar 16, 2017
856.26K
Sale
Mar 14
Form 4
250.00K
Mar 01, 2017
250.00K
Grant
Feb 27
Form 4
-7.81%
-1.80K
$16.94
-$30.49K
Feb 24, 2017
796.26K
Sale
ScheduledFeb 22
Form 4
$2.94
$164.60K
Jan 20, 2017
798.06K
Options
Jan 18
Form 4
$2.94
$100.00K
Jan 10, 2017
798.06K
Options
Jan 06
Form 4
-9.78%
-2.50K
Dec 08, 2016
708.06K
Grant
Dec 07
Form 4
$2.94
$882.00K
Nov 01, 2016
710.56K
Options
Oct 31
Form 4
-28.04%
-150.00K
$6.21
-$1.38M
Mar 11, 2016
410.56K
Sale
ScheduledMar 09
Form 4
235.00K
Mar 03, 2016
235.00K
Grant
Mar 01
Form 4
-21.68%
-152.15K
$5.04
-$1.06M
Feb 26, 2016
549.66K
Sale
ScheduledFeb 24
Form 4
$1.56
$100.00K
Jan 06, 2016
412.71K
Options
Jan 04
Form 4
4,809.97%
203.13K
Mar 18, 2015
517.35K
Grant
Mar 16
Form 4
-7.46%
-25.00K
$8.14
-$376.75K
Feb 23, 2015
314.22K
Sale
ScheduledFeb 19
Form 4
-5.63%
-20.00K
$7.12
-$260.60K
Nov 17, 2014
339.22K
Sale
ScheduledNov 13
Form 4
-6.58%
-25.00K
$7.27
-$333.25K
May 23, 2014
357.17K
Sale
ScheduledMay 22
Form 4
-6.17%
-25.00K
$6.14
-$276.75K
Apr 28, 2014
382.17K
Sale
ScheduledApr 24
Form 4
85.00K
Mar 05, 2014
85.00K
Grant
Mar 03
Form 4
-4.62%
-15.00K
$7.52
-$207.45K
Feb 20, 2014
312.17K
Sale
ScheduledFeb 18
Form 4
-5.80%
-20.00K
$7.49
-$275.60K
Jan 24, 2014
327.17K
Sale
ScheduledJan 23
Form 4
$0.60
$60.00K
Feb 21, 2013
345.00K
Options
Feb 20
Form 4
200.00K
Feb 05, 2013
200.00K
Grant
Feb 01
Form 4
110.00K
Feb 03, 2012
110.00K
Grant
Feb 01
Form 4
-8.70%
-20.00K
$7.89
-$291.40K
Apr 22, 2011
210.00K
Sale
ScheduledApr 21
Form 4
-6.17%
-15.14K
$7.80
-$217.97K
Apr 15, 2011
230.00K
Sale
ScheduledApr 14
Form 4
-9.21%
-24.86K
$7.80
-$358.03K
Apr 13, 2011
490.14K
Sale
ScheduledApr 11 - Apr 13
Form 4
-12.90%
-40.00K
$6.91
-$504.40K
Mar 22, 2011
270.00K
Sale
ScheduledMar 21
Form 4
-2.43%
-7.72K
$6.56
-$91.96K
Mar 04, 2011
310.00K
Sale
ScheduledMar 03
Form 4
-0.71%
-2.28K
$6.55
-$27.12K
Mar 01, 2011
317.72K
Sale
ScheduledFeb 25 - Feb 28
Form 4
-8.57%
-30.00K
$6.25
-$338.59K
Feb 23, 2011
320.00K
Sale
ScheduledFeb 22 - Feb 23
Form 4
110.00K
Feb 03, 2011
110.00K
Grant
Feb 01
Form 4
90.00K
Feb 04, 2010
90.00K
Grant
Feb 02
Form 3
Feb 02, 2010
210.00K
Showing 57 results

Cyclerion Therapeutics, Inc.

President and CSO
Updated Dec 30, 2020
Form 4
-7.40%
-20.11K
$3.01
-$60.52K
Dec 30, 2020
251.65K
Sale
Dec 28
Form 4
-15.54%
-50.00K
$2.52
-$125.75K
Dec 31, 2019
271.76K
Sale
Dec 27 - Dec 30
Form 4
75.00K
Nov 26, 2019
75.00K
Grant
Nov 22
Form 4/A
904.93K
Sep 20, 2019
904.93K
Grant
Apr 01
Form 4
1.25M
$14.81
$4.00M
Apr 03, 2019
1.25M
Purchase
Apr 01 - Apr 02
Form 3
Apr 03, 2019
Showing 6 results